Signifor Interactions
There are 404 drugs known to interact with Signifor (pasireotide), along with 6 disease interactions. Of the total drug interactions, 210 are major, 185 are moderate, and 9 are minor.
- View all 404 medications that may interact with Signifor
- View Signifor disease interactions (6)
Most frequently checked interactions
View interaction reports for Signifor (pasireotide) and the medicines listed below.
- Afinitor (everolimus)
- Arzerra (ofatumumab)
- bisoprolol
- Cortef (hydrocortisone)
- Cymbalta (duloxetine)
- Exjade (deferasirox)
- Farydak (panobinostat)
- Femara (letrozole)
- Gleevec (imatinib)
- Jadenu (deferasirox)
- Jakafi (ruxolitinib)
- Junel Fe 1 / 20 (ethinyl estradiol / norethindrone)
- Kisqali (ribociclib)
- Kymriah (tisagenlecleucel)
- Lasix (furosemide)
- Loestrin 21 1 / 20 (ethinyl estradiol / norethindrone)
- Maxalt (rizatriptan)
- Mekinist (trametinib)
- octreotide
- Proleukin (aldesleukin)
- Promacta (eltrombopag)
- Rydapt (midostaurin)
- Sandostatin (octreotide)
- Sandostatin LAR Depot (octreotide)
- Synthroid (levothyroxine)
- Tasigna (nilotinib)
- Tykerb (lapatinib)
- Votrient (pazopanib)
- Xanax (alprazolam)
- Zofran (ondansetron)
Signifor disease interactions
There are 6 disease interactions with Signifor (pasireotide) which include:
Report options
QR code containing a link to this page
More about Signifor (pasireotide)
- Signifor consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.